The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vincristine sulfate     Quarter: 2016Q3

Total Records: 443     Number of Pages: 23

DRUGNAME PT EventCount
VINCRISTINE SULFATE. Superior sagittal sinus thrombosis 2
VINCRISTINE SULFATE. Systemic mycosis 2
VINCRISTINE SULFATE. Thalamic infarction 2
VINCRISTINE SULFATE. Tumour lysis syndrome 2
VINCRISTINE SULFATE. Ventricular dysfunction 2
VINCRISTINE SULFATE. Vertigo 2
VINCRISTINE SULFATE. Weight decreased 2
VINCRISTINE SULFATE. Weight increased 2
VINCRISTINE SULFATE. White blood cell count decreased 2
VINCRISTINE SULFATE. Wound 2
VINCRISTINE SULFATE. Abdominal pain lower 1
VINCRISTINE SULFATE. Abscess fungal 1
VINCRISTINE SULFATE. Acidosis 1
VINCRISTINE SULFATE. Activated partial thromboplastin time prolonged 1
VINCRISTINE SULFATE. Acute motor-sensory axonal neuropathy 1
VINCRISTINE SULFATE. Acute respiratory distress syndrome 1
VINCRISTINE SULFATE. Acute respiratory failure 1
VINCRISTINE SULFATE. Adenovirus infection 1
VINCRISTINE SULFATE. Adenovirus test positive 1
VINCRISTINE SULFATE. Aggression 1

Total Records: 443     Number of Pages: 23